[Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer.

Name: [Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer.
Author: Xu, Yu-Hua

[Corrigendum] Overexpression of lncRNA EGFR‑AS1 is associated with a poor prognosis and promotes chemotherapy resistance in non‑small cell lung cancer. — المؤلف: Xu, Yu-Hua — International journal of oncology 20191220

المؤلف: Xu, Yu-Hua
النشر: International journal of oncology 20191220
الوصف: 340 p.